
Next month’s Narrative Friction report focuses on Alzheimer’s disease, exploring a significant pharmaceutical narrative and the areas in which the evidence and regulatory record invite closer review.

Please let me know when the report is released
We'll send one email when the June 2026 report goes live. Nothing else.